Huvepharma® announces Optigrid®45 medicated feed combination approvals
Posted on January 28, 2021
Blue Bird labels are now available for four combinations with the feed additive
Continue ReadingPharm to Farm: Learn about Huvepharma, Inc.’s mission to bring new choices to livestock producers
Posted on January 12, 2021
Animal health company Huvepharma, Inc. is working to provide new choices – and new possibilities – to the U.S. livestock sector.
Continue ReadingHuvepharma Focuses on Cutting Edge Fermintation and Manufacturing Technology
Posted on December 14, 2020
As animal health evolves Huvepharma continues to expand it's fermentation and manufacturing technology in Peshtera, Bulgaria by more then doubling the capacity.
Continue ReadingCitizen petition challenge withdrawn
Posted on December 02, 2020
On Friday, November 20, 2020, Elanco® Animal Health submitted a letter to FDA formally requesting withdrawal of their Citizen Petition. In that Citizen Petition, Elanco requested FDA to pull Monovet® 90, Huvepharma®, Inc.’s brand of monensin, from the market. Elanco, in requesting this withdrawal, has effectively agreed that Monovet® 90 has been proven safe and effective and is bioequivalent to the pioneer monensin
Continue ReadingHuvepharma Inc. Introduces New Vaccine to Combat Necrotic Enteritis
Posted on November 23, 2020
Huvepharma Inc. introduces AVERT™ NE, an innovative new vaccine to help control necrotic enteritis (NE) due to Clostridium perfringens Type A.
Continue Reading